Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenomethionine for Mucositis in Head and Neck Cancer
NCT01682031Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jun 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of selenomethionine in mucositis, sponsored by Roswell Park Comprehensive Cancer Center. Started Jun 2009; status: terminated.
02
Drugs
selenomethionine
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT01682031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01682031.